The role of STAT3 in antigen-IgG inducing regulatory CD4+Foxp3+T cells

Cellular Immunology

Volumn 246, Issue 2, 2007, Pages 103-109

  Wang, Renxi ^a   Han, Gencheng ^a   Wang, Jianan ^a   Song, Lun ^a   Chen, Guojiang ^a   Xu, Ruonan ^a   Yu, Ming ^a   Qian, Jiahua ^b   Shen, Beifen ^a   Li, Yan ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Foxp3; NOD mice; STAT3; Tolerance; Treg cells

Indexed keywords

CD4 IMMUNOGLOBULIN G2; GLUTAMATE DECARBOXYLASE; INTERLEUKIN 10; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS; ANTIGENS, CD4; FORKHEAD TRANSCRIPTION FACTORS; GLUTAMATE DECARBOXYLASE; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INTERLEUKIN-6; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NOD; SPLEEN; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TRANSCRIPTION, GENETIC;

MUS;

EID: 34548125234     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2007.07.001     Document Type: Article

References (40)

1. Adorini L., Gregori S., and Harrison L.C. Understanding autoimmune diabetes: insights from mouse models. Trends. Mol. Med. 8 (2002) 31-38
2. Atkinson M.A., and Leiter E.H. The NOD mouse model of type 1 diabetes: as good as it gets?. Nat. Med. 5 (1999) 601-604
3. Kikutani H., and Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51 (1992) 285-322
4. Chao C.C., and McDevitt H.O. Identification of immunogenic epitopes of GAD65 presented by Ag7 in non-obese diabetic mice. Immunogenetics 46 (1997) 29-34
5. Ji-Won Y., Chang-Soon Y., Hye-Won L., Huang Q.Q., Kang Y., Pyun K.H., Hirasawa K., Sherwin R.S., and Hee-Sook J. Control of autoimmune diabetes in NOD mice by GAD expression or suppression in cells. Science 284 (1999) 1183-1187
6. Kaufman D.L., Clare-Salzer M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E., Tobin A., and Lehmann P.L. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366 (1993) 69-72
7. Quinn A., and Sercarz E.E. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD (524-543). J. Autoimmun. 9 (1996) 365-370
8. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., and McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366 (1993) 72-75
9. Melo M., Qian J.H., EL-Amine M., Agarwal R.K., Soukhareva N., Kang Y., and Scott D.W. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J. Immunol. 168 (2002) 4788-4795
10. Song L., Wang J., Wang R., Yu M., Sun Y., Han G., Li Y., Qian J., Scott D.W., Kang Y., Soukhareva N., and Shen B. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-β?. Gene. Ther. 11 (2004) 1487-1496
11. Chinen J., and Shearer W.T. Advances in asthma, allergy and immunology series 2004: basic and clinical immunology. J. Allergy Clin. Immunol. 114 (2004) 398-405
12. Umetsu D.T., Akbari O., and Dekruyff R.H. Regulatory T cells control the development of allergic disease and asthma. J. Allergy Clin. Immunol. 112 (2003) 480-487
13. Frew A.J. Immunotherapy of allergic disease. J. Allergy Clin. Immunol. 111 (2003) s712-s719
14. Romagnani S. Immunologic influences on allergy and the Th1/Th2 balance. J. Allergy Clin. Immunol. 113 (2004) 395-400
15. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
16. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
17. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
18. Asseman C., Mauze S., Leach M.W., Coffman R.L., and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190 (1999) 995-1004
19. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., and Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199 (2004) 1455-1465
20. Borel Y. Haptens bound to self IgG induce immunologic tolerance, while when couped to syngeneic spleen cells they induce immune suppression. Immunol. Rev. 50 (1980) 71-104
21. Agarwal R.K., Kang Y., Zambidis E., Scott D.W., Chan C.C., and Caspi R.R. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J. Clin. Invest. 106 (2000) 245-252
22. Lei T.C., and Scott D.W. Induction of tolerance to factor VIII inhibitors by gene therapy with immunodominant A2 and C2 domains presented by B cells as Ig fusion proteins. Blood 105 (2005) 4865-4870
23. Bensinger S.J., Walsh P.T., Zhang J., Carroll M., Parsons R., Rathmell J.C., Thompson C.B., Burchill M.A., Farrar M.A., and Turka L.A. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J. Immunol. 172 (2004) 5287-5296
24. Pop S.M., Wong C.P., Culton D.A., Clarke S.H., and Tisch R. Single cell analysis shows decreasing Foxp3 and TGF-β1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes. J. Exp. Med. 201 (2005) 1333-1346
25. Su L., Creusot R.J., Gallo E.M., Chan S.M., Utz P.J., Fathman C.G., and Ermann J. Murine CD4+CD25+ regulatory T cells fail to undergo chromatin remodeling across the proximal promoter region of the IL-2 gene. J. Immunol. 173 (2004) 4994-5001
26. Shevach E.M., McHugh R.S., Piccirillo C.A., and Thornton A.M. Control of T-cell activation by CD4+CD25+ regulatory T cells. Immunol. Rev. 182 (2001) 58-67
27. Tang Q., Henriksen K.J., Boden E.K., Tooley A.J., Ye J., Subudhi S.K., Zheng X.X., Strom T.B., and Bluestone J.A. Cutting edge: CD28 controls peripheral homeostasis of CD4+CD25+ regulatory T cells. J. Immunol. 171 (2003) 3348-3352
28. Fehervari Z., and Sakaguchi S. Control of Foxp3+CD4+CD25+ regulatory T cells activation and function by dendritic cells. Int. Immunol. 16 (2004) 1769-1780
29. Manzotti C.N., Tipping H., Perry L.C., Mead K.I., Blair P.J., Zheng Y., and Sansom D.M. Inhibition of human T cell proliferation by CTLA-4 utilizeds CD80 and requires CD25+ regulatory T cells. Eur. J. Immunol. 32 (2002) 2888-2896
30. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., and Steinman R.M. Direct expansion of functional CD4+CD25+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198 (2003) 235-247
31. Zheng Y., Manzotti C.N., Liu M., Burke F., Mead K.I., and Sansom D.M. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J. Immunol. 172 (2004) 2778-2784
32. Darnell J.E. STATs and gene regulation. Science 277 (1997) 1630-1635
33. -/- mice. Immunity 13 (2000) 397-407
34. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., and Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
35. Welte T., Zhang S.S., Wang T., Zhang Z., Hesslein D.G., Yin Z., Kano A., Iwamoto Y., Li E., Craft J.E., Bothwell A.L., Fikrig E., Koni P.A., Flavell R.A., and Fu X.Y. STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc. Natl. Acad. Sci. USA 100 (2003) 1879-1884
36. Cheng F., Wang H.W., Cuenca A., Huang M., Ghansah T., Brayer J., Kerr W.G., Takeda K., Akira S., Schoenberger S.P., Yu H., Jove R., and Sotomayor E.M. A critical role for STAT3 signaling in immune tolerance. Immunity 19 (2003) 425-436
37. Park S.J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., and Hirano T. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 173 (2004) 3844-3854
38. Cui Y., Huang L., Elefteriou F., Yang G., Shelton J.M., Giles J.E., Oz O.K., Pourbahrami T., Lu C.Y., Richardson J.A., Karsenty G., and Li C. Essential role of STAT3 in body weight and glucose homeostasis. Mol. Cell. Biol. 24 (2004) 258-269
39. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., Shevach E.M., and O'shea J.J. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
40. Benkhart E.M., Siedlar M., Wedel A., Werner T., and Ziegler-Heitbrock H.W. Role of STAT3 in lipopolysaccharide-induced IL-10 gene expression. J. Immunol. 165 (2000) 1612-1617